Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Trading Statement

13 Feb 2008 09:40

Imaginatik PLC13 February 2008 13 February 2008 Imaginatik plc ("Imaginatik" or the "Company") Trading Update Imaginatik plc (AIM: IMTK), a leading provider of collaborative innovation andproblem-solving software and processes announces today that an improved tradingperformance in the second half of the year should result in a profit for thisperiod. This outcome is expected to strengthen the balance sheet and provide apositive operating cash flow for the second half year. The Company's recurringrevenue base continues to build well and will help underpin our operations intothe next financial year. In view of the weak trading experienced in the first half of the financial yearand not withstanding the much improved performance in the second half year, theCompany is unlikely to reach the market forecast of £4.4m of revenue for theyear to 31 March 2008. Overheads continue to be tightly contained. As a resultthe level of business required to reach break-even for the full year has beensignificantly reduced. Imaginatik also announces today that it is in final negotiations with a majorcustomer which may or may not lead to it becoming a strategic investor in theCompany. The Board will provide additional information to the market as soon asthe agreement is concluded. Mark Turrell, CEO of Imaginatik plc, commented, "I am pleased to see theCompany's performance improving after a difficult first nine months as a publiccompany. We now have a great deal of momentum within the business, our pipelineis strong and our recent presence at the World Economic Forum in Davos will helpaccelerate the current level of activity. We believe having a significantstrategic investor on board would be extremely positive for Imaginatik and itsshareholders and we will provide further information in due course." For further information please contact: Imaginatik plc Tel: +44 (0)20 7917 2975Mark Turrell, CEO / Shawn Taylor, CFO WH Ireland Tel: +44 (0)121 265 6330Tim Cofman/Katy Birkin Investor relations and UK mediaICIS Tel: +44 (0)20 7651 8688Tom Moriarty / Caroline Evans Jones About Imaginatik Imaginatik is the leading provider of Collaborative Innovation and ProblemSolving software and process to the world's leading companies. More than 100clients, including Hewlett-Packard, IBM and Pfizer, rely on Imaginatik'ssoftware, consulting and research to enable their best-of-breed innovationactivities. Imaginatik's software and consulting services have helped clients discoversignificant sources of additional revenue, as well as tangible cost savings,process improvements and increased product pipeline. Imaginatik is alsocommitted to developing strategic solutions in the field of innovation, workingwith academic institutions such as the London Business School and the CassSchool of Business, London, as well as leading practitioners of corporateinnovation. For further information please visit www.imaginatik.com. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
19th Dec 20083:16 pmRNSDirector/PDMR Shareholding
18th Dec 20089:45 amRNSDirector/PDMR Shareholding
17th Dec 20087:00 amRNSShare Option Schemes
1st Dec 20087:00 amRNSDirector's Disclosure Update
19th Nov 200812:39 pmRNSDirectors Dealing
13th Nov 20087:00 amRNSInterim Results
14th Oct 20087:00 amRNSTrading Statement
2nd Oct 20087:00 amRNSContract Win
30th Sep 20084:30 pmRNSTotal Voting Rights
24th Sep 20087:00 amRNSDirector/PDMR Shareholding
15th Sep 20087:00 amRNSContract Win
3rd Sep 20087:00 amRNSIssue of Equity
21st Aug 20087:00 amRNSContract Win
28th Jul 20089:27 amRNSNon-Executive Retirement
10th Jul 200810:20 amRNSResult of AGM
10th Jul 20087:00 amRNSAGM Statement
24th Jun 20087:00 amRNSDirector/PDMR Shareholding
18th Jun 200810:05 amRNSAnnual Report and Accounts
13th Jun 200812:16 pmRNSDirector/PDMR Shareholding
11th Jun 20087:00 amRNSFinal Results
1st Apr 200811:52 amRNSDirector Dealings
31st Mar 20084:30 pmRNSTotal Voting Rights
17th Mar 20082:57 pmRNSShare Subscription - Update
10th Mar 20082:23 pmRNSShare Subscription
10th Mar 20089:30 amRNSHolding(s) in Company
28th Feb 200810:01 amRNSPfizer Update
13th Feb 20089:40 amRNSTrading Statement
22nd Jan 20089:30 amRNSWorld Economic Forum
11th Jan 200810:13 amRNSMajor Contract Wins
30th Nov 20072:41 pmRNSWEF Technology Pioneer
14th Nov 20072:12 pmRNSInterim Results
16th Aug 200711:05 amRNSAgreement With IBM
14th Aug 20074:55 pmRNSAIM Rule 26 Information
27th Jul 200710:46 amRNSAGM Statement
27th Jul 20077:01 amRNSAGM Statement
11th Jul 200712:00 pmBUSGlobal Competition Forces Innovation and Collaboration Acceleration
29th Jun 20073:33 pmRNSAnnual Report and Accounts
13th Jun 200711:50 amRNSResult of EGM
12th Jun 20077:02 amRNSFinal Results
4th Jun 20077:02 amRNSUK & European Contract Wins
1st Jun 200710:29 amRNSNotice of Results
18th May 200710:05 amRNSNotice of EGM
23rd Apr 20072:38 pmBUSImaginatik Wins a Queens Award for Enterprise
23rd Apr 200711:02 amRNSWins A Queens Award
19th Apr 200710:59 amRNSDirector/PDMR Shareholding
21st Mar 20077:04 amRNSSenior Management Appointment
21st Mar 20077:01 amBUSImaginatik Appoints President, Americas and New CMO to Accommodate Growth
16th Mar 200711:45 amRNSTrading Statement
9th Feb 200711:30 amBUSImaginatik Appoints Managing Director in United Kingdom
9th Feb 20077:00 amRNSAppointment of UK MD

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.